Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

Manuela Giachelia, Maria Teresa Voso, Maria Chiara Tisi, Maurizio Martini, Valentina Bozzoli, Giuseppina Massini, Francesco D'Alo', Luigi Maria Larocca, Giuseppe Leone, Stefan Hohaus

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

28 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Neuroscience

Biochemistry, Genetics and Molecular Biology